{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:lidocaine-hydrochloride-injection",
  "slug": "lidocaine-hydrochloride-injection",
  "title": "FDA shortage status: Lidocaine Hydrochloride Injection",
  "ingredient": "Lidocaine Hydrochloride Injection",
  "status": "current",
  "source_statuses": [
    "Current",
    "To Be Discontinued"
  ],
  "brand_names": [
    "LIDOCAINE",
    "LIDOCAINE HYDROCHLORIDE",
    "LIDOCAINE HYDROCHLORIDE AND DEXTROSE",
    "XYLOCAINE",
    "XYLOCAINE MPF"
  ],
  "therapeutic_categories": [
    "Analgesia/Addiction",
    "Anesthesia",
    "Cardiovascular",
    "Pediatric"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "EPIDURAL",
    "INFILTRATION",
    "INTRACAUDAL",
    "INTRAVENOUS",
    "PERINEURAL",
    "RETROBULBAR",
    "TOPICAL"
  ],
  "package_count": 69,
  "packages": [
    {
      "package_ndc": "76329-3390-1",
      "product_ndc": "76329-3390",
      "company_name": "Amphastar Pharmaceuticals, Inc.",
      "manufacturer_name": "International Medication Systems, Limited",
      "presentation": "Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "83634-653-05",
      "product_ndc": "83634-651",
      "company_name": "Anthea Pharma",
      "manufacturer_name": "Avenacy, LLC",
      "presentation": "Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "83634-651-10",
      "product_ndc": "83634-651",
      "company_name": "Anthea Pharma",
      "manufacturer_name": "Avenacy, LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "83634-653-02",
      "product_ndc": "83634-651",
      "company_name": "Anthea Pharma",
      "manufacturer_name": "Avenacy, LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "83634-651-20",
      "product_ndc": "83634-651",
      "company_name": "Anthea Pharma",
      "manufacturer_name": "Avenacy, LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "83634-653-30",
      "product_ndc": "83634-651",
      "company_name": "Anthea Pharma",
      "manufacturer_name": "Avenacy, LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "83634-651-50",
      "product_ndc": "83634-651",
      "company_name": "Anthea Pharma",
      "manufacturer_name": "Avenacy, LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0264-9594-10",
      "product_ndc": "0264-9594",
      "company_name": "B. Braun Medical Inc.",
      "manufacturer_name": "B. Braun Medical Inc.",
      "presentation": "Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "10/25/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0264-9594-20",
      "product_ndc": "0264-9594",
      "company_name": "B. Braun Medical Inc.",
      "manufacturer_name": "B. Braun Medical Inc.",
      "presentation": "Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "10/25/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0264-9598-20",
      "product_ndc": "0264-9594",
      "company_name": "B. Braun Medical Inc.",
      "manufacturer_name": "B. Braun Medical Inc.",
      "presentation": "Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "10/25/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0338-0409-03",
      "product_ndc": "0338-0409",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Corporation",
      "presentation": "Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "10/25/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0338-0411-02",
      "product_ndc": "0338-0409",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Corporation",
      "presentation": "Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "10/25/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-159-74",
      "product_ndc": "55150-158",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-161-02",
      "product_ndc": "55150-161",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-162-05",
      "product_ndc": "55150-161",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-163-30",
      "product_ndc": "55150-161",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-251-10",
      "product_ndc": "55150-251",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "06/13/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-252-20",
      "product_ndc": "55150-251",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "06/13/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-165-05",
      "product_ndc": "55150-161",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-164-02",
      "product_ndc": "55150-161",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-254-10",
      "product_ndc": "55150-251",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "06/13/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-255-20",
      "product_ndc": "55150-251",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "06/13/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-256-50",
      "product_ndc": "55150-251",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "06/13/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-201-02",
      "product_ndc": "63323-201",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-208-05",
      "product_ndc": "63323-208",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-201-10",
      "product_ndc": "63323-201",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-202-02",
      "product_ndc": "63323-201",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-485-27",
      "product_ndc": "63323-481",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-485-57",
      "product_ndc": "63323-481",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-492-27",
      "product_ndc": "63323-481",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-492-31",
      "product_ndc": "63323-481",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-492-37",
      "product_ndc": "63323-481",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-492-57",
      "product_ndc": "63323-481",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-493-91",
      "product_ndc": "63323-492",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-493-97",
      "product_ndc": "63323-492",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-486-17",
      "product_ndc": "63323-481",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-486-27",
      "product_ndc": "63323-481",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-486-57",
      "product_ndc": "63323-481",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-495-07",
      "product_ndc": "63323-481",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-495-27",
      "product_ndc": "63323-481",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-496-97",
      "product_ndc": "63323-492",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-484-57",
      "product_ndc": "63323-481",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-491-57",
      "product_ndc": "63323-481",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0143-9577-10",
      "product_ndc": "0143-9172",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "06/13/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0143-9575-10",
      "product_ndc": "0143-9172",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "06/13/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0143-9595-25",
      "product_ndc": "0143-9594",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "06/13/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0143-9594-25",
      "product_ndc": "0143-9594",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "06/13/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4277-02",
      "product_ndc": "0409-4275",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4276-01",
      "product_ndc": "0409-4275",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4275-01",
      "product_ndc": "0409-4275",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4277-01",
      "product_ndc": "0409-4275",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4276-02",
      "product_ndc": "0409-4275",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1323-05",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-9137-05",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4713-32",
      "product_ndc": "0409-4275",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4283-01",
      "product_ndc": "0409-4283",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "RETROBULBAR",
        "TOPICAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4776-01",
      "product_ndc": "0409-4275",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4713-02",
      "product_ndc": "0409-4275",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4904-34",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Lidocaine Hydrochloride, Injection, 1%, USP (For Cardiac Use Only) 50 mg/5 mL (10 mg/mL) LifeShield\u2122 ABBOJECT\u00ae Glass Syringe (20 G x 1 1/2) (NDC 0409-4904-34)\"",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "11/07/2025",
      "initial_posting_date": "11/07/2025",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2066-05",
      "product_ndc": "0409-2066",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4903-34",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Lidocaine Hydrochloride, Injection, 100 mg/5mL (2%, 20 mg/1 mL) Syringes (NDC 0409-4903-34)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4903-34",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Lidocaine Hydrochloride, Injection, 2%, USP (For Cardiac Use Only)  100 mg/5 mL (20 mg/mL) LifeShield\u00ae ABBOJECT\u00ae Glass Syringe (20 G x 1 1/2) (NDC 0409-4903-34)\"",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "11/07/2025",
      "initial_posting_date": "11/07/2025",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4282-02",
      "product_ndc": "0409-4275",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4278-01",
      "product_ndc": "0409-4275",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4279-02",
      "product_ndc": "0409-4275",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4282-01",
      "product_ndc": "0409-4275",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4904-34",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Lidocaine Hydrochloride, Injection, 50 mg/5mL (1%,10 mg/1 mL) Syringes (NDC 0409-4904-34)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/22/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "73293-0001-2",
      "product_ndc": "73293-0001",
      "company_name": "Huons Co., Ltd. (South Korea)",
      "manufacturer_name": "Huons Co., Ltd.",
      "presentation": "Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "07/30/2026",
      "initial_posting_date": "07/14/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "65282-1605-1",
      "product_ndc": "65282-1605",
      "company_name": "Spectra Medical Devices, LLC",
      "manufacturer_name": "Spectra Medical Devices, LLC",
      "presentation": "Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "05/15/2026",
      "initial_posting_date": "06/14/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 47,
    "Limited Availability": 2,
    "Unavailable": 18
  },
  "initial_posting_date": "02/20/2018",
  "latest_source_update": "11/07/2025",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}